- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cyclopharm Ltd (CYC)
The Cyclopharm Ltd share price today is 0.705 %REPORT_CURRENCY%, view ASX CYC stock exchange data. Track the latest Cyclopharm Ltd share price with real-time updates on CYC stock performance including market cap, day range, 52-week range and dividend yield. Access CYC charts, earnings dates and analyst estimates to support your investment decisions.
Sydney
Currency in AUD
0.705
-0.020(-2.76%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.705
0.735
52 wk Range
0.560
1.475
CYC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7050.735
52 wk Range
0.5601.475
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CYC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
1.003
Upside
+42.22%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.
Compare CYC to Peers and Sector
Metrics to compare | CYC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCYCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.4x | −2.0x | −0.5x | |
PEG Ratio | 0.25 | 0.08 | 0.00 | |
Price/Book | 3.4x | 2.9x | 2.6x | |
Price / LTM Sales | 2.9x | 2.3x | 3.2x | |
Upside (Analyst Target) | 76.9% | 99.7% | 47.4% | |
Fair Value Upside | Unlock | 14.2% | 7.7% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.003
(+42.22% Upside)
Earnings
Latest Release
25-02-2026
EPS / Forecast
-0.09 / --
Revenue / Forecast
16.9M / --
FAQ
What Is the Cyclopharm Ltd (CYC) Share Price Today?
The Cyclopharm Ltd share price today is 0.705 AUD.
What is the current Cyclopharm Ltd (CYC) share price and day range?
As of 25-04-2026, the Cyclopharm Ltd share price is 0.705 AUD, with a previous close of 0.725 AUD. The share price has ranged from 0.705 to 0.735 AUD today, while the 52-week range spans from 0.560 to 1.475 AUD.
What Is the Cyclopharm Ltd Market Cap?
As of today, Cyclopharm Ltd market cap is 88.880M.
What Is the Cyclopharm Ltd (CYC) Share Price Target?
The average 12-month share price target for Cyclopharm Ltd is 1.003 AUD, with a high estimate of 1.00265697 AUD and a low estimate of 1.00265697 AUD. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +42.22% Upside potential.
What Is Cyclopharm Ltd's Earnings Per Share (TTM)?
The Cyclopharm Ltd EPS (TTM) is -0.156.
From a Technical Analysis Perspective, Is CYC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Cyclopharm Ltd Trade On?
Cyclopharm Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Cyclopharm Ltd?
The stock symbol for Cyclopharm Ltd is "CYC."
How Many Times Has Cyclopharm Ltd Stock Split?
Cyclopharm Ltd has split 3 times.
How Many Employees Does Cyclopharm Ltd Have?
Cyclopharm Ltd has 109 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.